ATGCCo

ATGCCo is a biotechnology R&D company headquartered in South Korea, dedicated to biopharmaceutical research and development. The ATGC management team has extensive experience in the development of botulinum toxin products and currently has multiple pharmaceutical R&D projects in preclinical and clinical stages.